Thu, Jun 5, 2025
[Archive]
Volume 33, Issue 156 (January & February 2025)
J Adv Med Biomed Res 2025, 33(156): 48-59 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Banihashemian F, Jalali Nadoushan A H, Safdarian M, Rafieian Koopaiee M, Rezvankhah T, Alavi K. Psychometric Evaluation of Persian Translation for Recovery Assessment Scale - Domains and Stages (RAS-DS) Questionnaire in Patients with Schizophrenia and Major Mood Disorders. J Adv Med Biomed Res 2025; 33 (156) :48-59
URL: http://journal.zums.ac.ir/article-1-7445-en.html
URL: http://journal.zums.ac.ir/article-1-7445-en.html
Fatemeh Banihashemian1 
, Amir Hossein Jalali Nadoushan1 , Mahdi Safdarian2 , Maryam Rafieian Koopaiee1 , Tara Rezvankhah1 , Kaveh Alavi *3
, Amir Hossein Jalali Nadoushan1 , Mahdi Safdarian2 , Maryam Rafieian Koopaiee1 , Tara Rezvankhah1 , Kaveh Alavi *3
1- Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
2- Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran & Department of Neurology, Neurocritical Care and Neurorehabilitation, Christian Doppler University Hospital, Centre of Cognitive Neuroscience, Paracelsus Medical University, Salzburg, Austria
3- Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran ,mahdisafdarian@gmail.com
2- Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran & Department of Neurology, Neurocritical Care and Neurorehabilitation, Christian Doppler University Hospital, Centre of Cognitive Neuroscience, Paracelsus Medical University, Salzburg, Austria
3- Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran ,
Abstract: (461 Views)
Objectives and Aims: Considering the lack of quantitative measurement tools to monitor recovery in the patients with schizophrenia spectrum or major mood disorders in Iranian patients, this study was designed to determine the validity and reliability for the Persian translation of self-report questionnaire Recovery Assessment Scale: domains and stages (RAS-DS).
Methods: The Persian version of RAS-DS was prepared via an independent translation process. Sampling was done from in- and outpatients referred to Iran Psychiatric Hospital. Patients completed demographic information datasheet, WHO quality of life - Brief Form (WHOQoL-BREF), Depression, Anxiety, Stress Scale (DASS-21), and translated RAS-DS questionnaires, in addition to Brief Psychiatric Rating Scale (BPRS). Twenty patients completed the RAS-DS and WHOQoL-BREF for the follow-up evaluation in two to four weeks.
Results: 142 patients (81 men and 61 women) participated in this study with an average age of 35.4 (± 9.2) years. The intensity of depression, anxiety, and stress (DASS-21) exhibited a significant negative correlation with all domains of RAS-DS, while the various domains of quality of life (WHOQoL-BREF) exhibited a positive and significant correlation. All domains of RAS-DS had positive significant correlations with each other, and with the total score of questionnaire. Cronbach's alpha coefficient was calculated as 0.960 for the whole questionnaire and 0.835, 0.944, 0.881, and 0.815 for its four domains, respectively.
Conclusion: Persian translation of RAS-DS questionnaire has good reliability and validity, as well as acceptable internal consistency, and could therefore be used to conduct research in the field of recovery for Iranian patients with schizophrenia spectrum and major mood disorders.
Keywords: Bipolar Disorder, Depressive Disorder, Major, Mental Health Recovery, Schizophrenia, Surveys and Questionnaires
Type of Study: Original Research Article |
Subject:
Clinical Medicine
Received: 2024/12/2 | Accepted: 2025/03/4 | Published: 2025/03/13
Received: 2024/12/2 | Accepted: 2025/03/4 | Published: 2025/03/13
References
1. GBD 2015 Eastern Mediterranean Region Mental Health Collaborators. The burden of mental disorders in the Eastern Mediterranean region, 1990–2015: findings from the global burden of disease 2015 study. Int J Public Health. 2018;63(Suppl 1):25-37. [DOI:10.1007/s00038-017-1006-1] [PMID] [PMCID]
2. Silva SA, Silva SU, Ronca DB, Gonçalves VSS, Dutra ES, Carvalho KMB. Common mental disorders prevalence in adolescents: A systematic review and meta-analyses. PloS One. 2020;15(4):e0232007. [DOI:10.1371/journal.pone.0232007] [PMID] [PMCID]
3. GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022;9(2):137-50. [DOI:10.1016/S2215-0366(21)00395-3] [PMID]
4. Khanam D, McDonald K, Neils CW. Measuring recovery: a toolkit for mental health providers in New York City. New York: The Bureau of Mental Health, NYC Department of Health and Mental Hygiene. 2013.
5. Farhoudian A, Sharifi V, Amini H, Basirnia A, Mesgarpour B, Mansouri N, et al. Prevalence of psychiatric disorders in Iran: A systematic review. Iran J Psychiatry. 2007;2(4):137-50.
6. Rahimi-Movaghar A, Amin-Esmaeili M, Sharifi V, Hajebi A, Radgoodarzi R, Hefazi M, et al. Iranian mental health survey: design and field proced. Iran J Psychiatry. 2014;9(2):96-109.
7. Sharifi V, Amin-Esmaeili M, Hajebi A, Motevalian A, Radgoodarzi R, Hefazi M, et al. Twelve-month prevalence and correlates of psychiatric disorders in Iran: the Iranian Mental Health Survey, 2011. Arch Iran Med. 2015;18(2):76-84.
8. Trautmann S, Rehm J, Wittchen HU. The economic costs of mental disorders: Do our societies react appropriately to the burden of mental disorders?. EMBO Rep. 2016;17(9):1245-9. [DOI:10.15252/embr.201642951] [PMID] [PMCID]
9. Slade M, Amering M, Farkas M, Hamilton B, O'Hagan M, Panther G, et al. Uses and abuses of recovery: implementing recovery‐oriented practices in mental health systems. World Psychiatry. 2014;13(1):12-20. [DOI:10.1002/wps.20084] [PMID] [PMCID]
10. Roe D, Chopra M, Wagner B, Katz G, Rudnick A. The emerging self in conceptualizing and treating mental illness. J Psychosoc Nurs Ment Health Serv. 2004;42(2):32-40. [DOI:10.3928/02793695-20040201-06] [PMID]
11. Clarke SP, Oades LG, Crowe TP, Deane FP. Collaborative goal technology: theory and practice. Psychiatr Rehabil J. 2006;30(2):129. [DOI:10.2975/30.2006.129.136] [PMID]
12. Mueser KT, Meyer PS, Penn DL, Clancy R, Clancy DM, Salyers MP. The Illness Management and Recovery program: rationale, development, and preliminary findings. Schizophr Bull. 2006;32(suppl_1):S32-43. [DOI:10.1093/schbul/sbl022] [PMID] [PMCID]
13. Andresen R, Caputi P, Oades L. Stages of recovery instrument: development of a measure of recovery from serious mental illness. Aust N Z J Psychiatry 2006;40(11-12):972-80. [DOI:10.1111/j.1440-1614.2006.01921.x]
14. Thornicroft G, Slade M. New trends in assessing the outcomes of mental health interventions. World Psychiatry. 2014;13(2):118-24. [DOI:10.1002/wps.20114] [PMID] [PMCID]
15. Sklar M, Groessl EJ, O'Connell M, Davidson L, Aarons GA. Instruments for measuring mental health recovery: a systematic review. Clin Psychol Rev. 2013;33(8):1082-95. [DOI:10.1016/j.cpr.2013.08.002] [PMID]
16. Scheyett A, DeLuca J, Morgan C. Recovery in severe mental illnesses: A literature review of recovery measures. Soc Work Res. 2013;37(3):286-303. [DOI:10.1093/swr/svt018]
17. Leamy M, Foye U, Hirrich A, Bjørgen D, Silver J, Simpson A, et al. A systematic review of measures of the personal recovery orientation of mental health services and staff. Int J Ment Health Syst. 2023;17(1):33. [DOI:10.1186/s13033-023-00600-y] [PMID] [PMCID]
18. Barbic S, Krupa T, Armstrong I. A randomized controlled trial of the effectiveness of a modified recovery workbook program: preliminary findings. Psychiatr Serv. 2009;60(4):491-7. [DOI:10.1176/ps.2009.60.4.491] [PMID]
19. Oades L, Deane F, Crowe T, Gordon Lambert W, Kavanagh D, Lloyd C. Collaborative recovery: An integrativemodel for working with individuals who experience chronic and recurring mental illness. Australas Psychiatry. 2005;13(3):279-84. [DOI:10.1111/j.1440-1665.2005.02202.x] [PMID]
20. Hancock N, Scanlan JN, Honey A, Bundy AC, O’Shea K. Recovery assessment scale–domains and stages (RAS-DS): its feasibility and outcome measurement capacity. Aust N Z J Psychiatry. 2015;49(7):624-33. [DOI:10.1177/0004867414564084] [PMID] [PMCID]
21. Corrigan PW, Phelan SM. Social support and recovery in people with serious mental illnesses. Community Ment Health J. 2004;40:513-23. [DOI:10.1007/s10597-004-6125-5] [PMID]
22. Corrigan PW. Impact of consumer-operated services on empowerment and recovery of people with psychiatric disabilities. Psychiatr Serv. 2006;57(10):1493-6. [DOI:10.1176/ps.2006.57.10.1493] [PMID]
23. Hendryx M, Green CA, Perrin NA. Social support, activities, and recovery from serious mental illness: STARS study findings. J Behav Health Serv Res. 2009;36:320-9. [DOI:10.1007/s11414-008-9151-1] [PMID] [PMCID]
24. McNaught M, Caputi P, Oades LG, Deane FP. Testing the validity of the Recovery Assessment Scale using an Australian sample. Aust N Z J Psychiatry. 2007;41(5):450-7. [DOI:10.1080/00048670701264792] [PMID]
25. Chiba R, Miyamoto Y, Kawakami N. Reliability and validity of the Japanese version of the Recovery Assessment Scale (RAS) for people with chronic mental illness: Scale development. Int J Nurs Stud. 2010;47(3):314-22. [DOI:10.1016/j.ijnurstu.2009.07.006] [PMID]
26. Jorge-Monteiro MF, Ornelas JH. Recovery Assessment Scale: Testing validity with Portuguese community-based mental health organization users. Psychol Assess. 2016;28(3):e1-e11. [DOI:10.1037/pas0000176] [PMID]
27. Cavelti M, Wirtz M, Corrigan P, Vauth R. Recovery assessment scale: examining the factor structure of the German version (RAS-G) in people with schizophrenia spectrum disorders. Eur Psychiatry. 2017;41(1):60-7. [DOI:10.1016/j.eurpsy.2016.10.006] [PMID]
28. Shera W, Ramon S. Challenges in the implementation of recovery-oriented mental health policies and services: Analysis of developments in England and Canada. Int J Ment Health. 2013;42(2-3):17-42. [DOI:10.2753/IMH0020-7411420202]
29. Fukui S, Salyers MP. Assessing the recovery assessment scale across time. Psychiatr Serv. 2021;72(6):716-9. [DOI:10.1176/appi.ps.202000521] [PMID] [PMCID]
30. Lawshe CH. A quantitative approach to content validity. Pers Psychol. 1975;28(4):563-75. [DOI:10.1111/j.1744-6570.1975.tb01393.x]
31. The Whoqol Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med. 1998;28(3):551-8. [DOI:10.1017/S0033291798006667] [PMID]
32. Usefy AR, Ghassemi GR, Sarrafzadegan N, Mallik S, Baghaei AM, Rabiei K. Psychometric properties of the WHOQOL-BREF in an Iranian adult sample. Community Ment Health J. 2010;46:139-47. [DOI:10.1007/s10597-009-9282-8] [DOI:10.1007/s10597-010-9292-6] [PMID]
33. Lovibond PF, Lovibond SH, Psychology Foundation of A. Manual for the depression anxiety stress scales. 2nd ed ed. Sydney, N.S.W.: Psychology Foundation of Australia Sydney, N.S.W.; 1995. [DOI:10.1037/t01004-000]
34. Asghari A, Saed F, Dibajnia P. Psychometric properties of the Depression Anxiety Stress Scales-21 (DASS-21) in a non-clinical Iranian sample. Int J psychol. 2008;2(2):82-102.
35. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep. 1962;10:799-812. [DOI:10.2466/pr0.1962.10.3.799]
36. Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel R. Clinical implications of Brief Psychiatric Rating Scale scores. Br J Psychiatry. 2005;187(4):366-71. [DOI:10.1192/bjp.187.4.366] [PMID]
37. Shabani A, Masoumian S, Zamirinejad S, Hejri M, Pirmorad T, Yaghmaeezadeh H. Psychometric properties of structured clinical interview for DSM‐5 disorders‐clinician version (SCID‐5‐CV). Brain Behav. 2021;11(5):e01894. [DOI:10.1002/brb3.1894] [PMID] [PMCID]
38. Hancock N, Scanlan JN, Kightley M, Harris A. Recovery Assessment Scale‐Domains and Stages: Measurement capacity, relevance, acceptability and feasibility of use with young people. Early Interv Psychiatry. 2020;14(2):179-87. [DOI:10.1111/eip.12842] [PMID]
39. Scanlan JN, Hancock N, Honey A. The Recovery Assessment Scale–Domains and Stages (RAS-DS): sensitivity to change over time and convergent validity with level of unmet need. Psychiatry Res. 2018;261:560-4. [DOI:10.1016/j.psychres.2018.01.042] [PMID]
40. Harrison V. A biologist’s view of pain, suffering and marginal life. The depraved, the disabled and the fullness of life. Delaware: Michael Glazier. 1984.
41. De Silva KT, Cockshaw WD, Rehm IC, Hancock N. A short form of the Recovery Assessment Scale‐Domains and Stages: Development and validation among adults with anxiety disorders. Clin Psychol Psychother. 2021;28(5):1135-45. [DOI:10.1002/cpp.2563] [PMID]
42. Chan RC, Mak WW, Chio FH, Tong AC. Flourishing with psychosis: a prospective examination on the interactions between clinical, functional, and personal recovery processes on well-being among individuals with schizophrenia spectrum disorders. Schizophr Bull. 2018;44(4):778-86. [DOI:10.1093/schbul/sbx120] [PMID] [PMCID]
43. Anthony WA. Recovery from mental illness: the guiding vision of the mental health service system in the 1990s. Psychiatr Rehabil J. 1993;16(4):11. [DOI:10.1037/h0095655]
44. Kightley M, Einfeld S, Hancock N. Routine outcome measurement in mental health: feasibility for examining effectiveness of an NGO. Australas Psychiatry. 2010;18(2):167-9. [DOI:10.3109/10398560903473660] [PMID]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Copyright Policy
